These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 8992285

  • 1. [Celiac disease associated with major thalassemia. A case report].
    Mangiagli A, Campisi S.
    Minerva Pediatr; 1996 Sep; 48(9):401-5. PubMed ID: 8992285
    [Abstract] [Full Text] [Related]

  • 2. Cardiac disease in beta-thalassaemia major: Is it reversible?
    Atiq M, Bana M, Ahmed US, Bano S, Yousuf M, Fadoo Z, Khurshid M.
    Singapore Med J; 2006 Aug; 47(8):693-6. PubMed ID: 16865210
    [Abstract] [Full Text] [Related]

  • 3. Celiac disease in a child with beta-thalassemia major: a need for improved screening and awareness.
    Parakh A, Sudha S, Dubey AP, Gupta A.
    J Pediatr Hematol Oncol; 2008 Dec; 30(12):913-4. PubMed ID: 19131778
    [Abstract] [Full Text] [Related]

  • 4. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
    Mokhtar GM, Tantawy AA, Adly AA, Ismail EA.
    Hemoglobin; 2011 Dec; 35(4):382-405. PubMed ID: 21797705
    [Abstract] [Full Text] [Related]

  • 5. Combined therapy of silymarin and desferrioxamine in patients with beta-thalassemia major: a randomized double-blind clinical trial.
    Gharagozloo M, Moayedi B, Zakerinia M, Hamidi M, Karimi M, Maracy M, Amirghofran Z.
    Fundam Clin Pharmacol; 2009 Jun; 23(3):359-65. PubMed ID: 19453758
    [Abstract] [Full Text] [Related]

  • 6. Linear growth in homozygous beta-thalassemia and beta-thalassemia/hemoglobin E patients under different treatment regimens.
    Viprakasit V, Tanphaichitr VS, Mahasandana C, Assteerawatt A, Suwantol L, Veerakul G, Kankirawatana S, Pung-Amritt P, Suvatte V.
    J Med Assoc Thai; 2001 Jul; 84(7):929-41. PubMed ID: 11759973
    [Abstract] [Full Text] [Related]

  • 7. Pulmonary hypertension and beta-thalassemia major: report of a case, its treatment, and a review of the literature.
    Tam DH, Farber HW.
    Am J Hematol; 2006 Jun; 81(6):443-7. PubMed ID: 16680745
    [Abstract] [Full Text] [Related]

  • 8. Beta-thalassemia and pulmonary function.
    Piatti G, Allegra L, Ambrosetti U, Cappellini MD, Turati F, Fiorelli G.
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [Abstract] [Full Text] [Related]

  • 9. Successful desensitization of a case with desferrioxamine hypersensitivity.
    Gülen F, Demir E, Tanaç R, Aydinok Y, Gulen H, Yenigün A, Can D.
    Minerva Pediatr; 2006 Dec; 58(6):571-4. PubMed ID: 17093379
    [Abstract] [Full Text] [Related]

  • 10. Sensory neural hearing loss in beta-thalassemia major patients treated with deferoxamine.
    Shamsian BS, Aminasnafi A, Moghadassian H, Gachkar L, Arzanian MT, Alavi S, Esfehani H, Garallahi F, Amini R.
    Pediatr Hematol Oncol; 2008 Sep; 25(6):502-8. PubMed ID: 18728969
    [Abstract] [Full Text] [Related]

  • 11. Zinc status in patients with major beta-thalassemia.
    Mehdizadeh M, Zamani G, Tabatabaee S.
    Pediatr Hematol Oncol; 2008 Sep; 25(1):49-54. PubMed ID: 18231954
    [Abstract] [Full Text] [Related]

  • 12. Severe infections in thalassaemic patients: prevalence and predisposing factors.
    Rahav G, Volach V, Shapiro M, Rund D, Rachmilewitz EA, Goldfarb A.
    Br J Haematol; 2006 Jun; 133(6):667-74. PubMed ID: 16704445
    [Abstract] [Full Text] [Related]

  • 13. Intensification of chelating-therapy in patients with thalassemia major.
    Laws HJ, Göbel U, Christaras A, Janssen G.
    Klin Padiatr; 2005 Jun; 217(3):120-5. PubMed ID: 15858702
    [Abstract] [Full Text] [Related]

  • 14. Growth and puberty in thalassemia major.
    Raiola G, Galati MC, De Sanctis V, Caruso Nicoletti M, Pintor C, De Simone M, Arcuri VM, Anastasi S.
    J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():259-66. PubMed ID: 12729401
    [Abstract] [Full Text] [Related]

  • 15. [Celiac disease today].
    Premate FM.
    Clin Ter; 1996 Oct; 147(10):495-503. PubMed ID: 9264902
    [Abstract] [Full Text] [Related]

  • 16. Malnutrition and growth abnormalities in children with beta thalassemia major.
    Tienboon P, Sanguansermsri T, Fuchs GJ.
    Southeast Asian J Trop Med Public Health; 1996 Jun; 27(2):356-61. PubMed ID: 9280002
    [Abstract] [Full Text] [Related]

  • 17. Zinc deficiency aggravates abnormal glucose metabolism in thalassemia major patients.
    Dehshal MH, Hooghooghi AH, Kebryaeezadeh A, Kheirabadi M, Kazemi S, Nasseh A, Shariftabrizi A, Pasalar P.
    Med Sci Monit; 2007 May; 13(5):CR235-9. PubMed ID: 17476196
    [Abstract] [Full Text] [Related]

  • 18. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG, Autio KA, Mait JE, Schneider R, Lesser M, Giardina PJ.
    Ann N Y Acad Sci; 2005 May; 1054():462-6. PubMed ID: 16339698
    [Abstract] [Full Text] [Related]

  • 19. [Celiac disease (familial) associated with sarcoidosis. Clinical case and review of the literature].
    Bianconcini G, Mazzali F, Candini R, Silingardi M, Iori I.
    Minerva Med; 1994 Oct; 85(10):541-53. PubMed ID: 7800197
    [Abstract] [Full Text] [Related]

  • 20. A simple model to assess and improve adherence to iron chelation therapy with deferoxamine in patients with thalassemia.
    Pakbaz Z, Fischer R, Treadwell M, Yamashita R, Fung EB, Calvelli L, Quirolo K, Foote D, Harmatz P, Vichinsky EP.
    Ann N Y Acad Sci; 2005 Oct; 1054():486-91. PubMed ID: 16339703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.